User profiles for Andrew D. Redd
 | Andrew D ReddNIAID, NIH Verified email at jhmi.edu Cited by 6653 |
[HTML][HTML] Antiretroviral therapy for the prevention of HIV-1 transmission
…, M Essex, SE Hudelson, AD Redd… - … England Journal of …, 2016 - Mass Medical Soc
Background An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052
trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked …
trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked …
[HTML][HTML] Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …
[HTML][HTML] SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Characterization of the T cell response in individuals who recover from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
Accurate serological assays to detect antibodies to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8+ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
There is a growing concern that ongoing evolution of SARS-CoV-2 could lead to variants of
concern (VOC) that are capable of avoiding some or all of the multifaceted immune response …
concern (VOC) that are capable of avoiding some or all of the multifaceted immune response …
SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. …
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. …
[HTML][HTML] Frequency and implications of HIV superinfection
HIV superinfection occurs when an individual with HIV is infected with a new distinct HIV viral
strain. Superinfection has been reported throughout the world, and studies have recorded …
strain. Superinfection has been reported throughout the world, and studies have recorded …
CD8+ T-cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
This study examined whether CD8+ T-cell responses from coronavirus disease 2019
convalescent individuals (n = 30) potentially maintain recognition of the major severe acute …
convalescent individuals (n = 30) potentially maintain recognition of the major severe acute …
[PDF][PDF] Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
It is unclear why some SARS-CoV-2 patients readily resolve infection while others develop
severe disease. By interrogating metabolic programs of immune cells in severe and …
severe disease. By interrogating metabolic programs of immune cells in severe and …
[HTML][HTML] The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric …
Background It is often assumed that local sexual networks play a dominant role in HIV
spread in sub-Saharan Africa. The aim of this study was to determine the extent to which …
spread in sub-Saharan Africa. The aim of this study was to determine the extent to which …